Full-Time
Vice President Senior Benefits Consultant
Posted on 8/21/2026
Brown & Brown Insurance
5,001-10,000 employees
Provides risk management and insurance solutions
No salary listed
Plano, TX, USA
Hybrid
Hybrid role in Plano; routine or periodic travel may be required.
Bachelor's
 Consulting (1) |
|---|
Get referred to Brown & Brown Insurance
See people who can refer or advise you
- A minimum four-year degree or equivalent work experience.
- At least 9 years of employee benefits experience with thorough understanding and knowledge of employee benefits.
- At least 4 years of financial experience.
- Proficiency with Microsoft Office Suite.
- Strong to expert-level Microsoft Excel skills.
- Ability to maintain a high level of confidentiality.
- Strong analytical and critical-thinking ability.
- Ability to work independently.
- Detail-oriented with strong organizational skills.
- Must obtain and maintain an active Life, Accident and Health Insurance Agent License.
- Acceptable motor vehicle record results at hire and periodically thereafter, along with minimum acceptable insurance coverage, if driving is required.
- Manage a book of business, including retention and growth.
- Develop and execute client benefits strategies.
- Advise clients independently on all areas of compliance.
- Perform compliance, benchmarking, renewal and marketing, reporting and analytics functions with minimal guidance.
- Serve as a strategic resource for financial strategy and client escalations.
- Monitor, prepare and review monthly financial reports and send them to clients with analysis of activity and large-claim details.
- Prepare financial and underwriting exhibits, including financial projections, large-claim analysis, specific stop-loss analysis, demographics analysis and incurred but not reported analysis.
- Develop reporting requirements and manage deviations or customizations in reports.
- Lead client meetings and presentations and onboard new clients.
- Participate in market meetings, seminars and training programs.
- Provide guidance and training to Consultants, Account Managers and Analysts.
- Manage day-to-day client contact and employee benefits account-management, marketing, renewal and daily service functions.
- Evaluate client financial and utilization metrics, including monthly financial reports, utilization metrics, benchmarks and ad hoc reports and analyses.
- Assist the Team Lead with the financial consulting needs of employee benefits clients.
Brown & Brown provides risk management and insurance solutions to businesses and individuals through its Retail and Specialty Distribution segments. The company works by acting as an intermediary to identify specific risks and connect customers with tailored insurance policies that protect their assets. Unlike many competitors, it combines the scale of a large global brokerage with a decentralized culture that emphasizes local community involvement and a team-based approach to service. Its goal is to provide superior risk protection and long-term security for customers by consistently prioritizing their best interests.
Company Size
5,001-10,000
Company Stage
IPO
Headquarters
Leeds, United Kingdom
Founded
1914
Get referred to Brown & Brown Insurance
See people who can refer or advise you
Simplify's Take
What believers are saying
- Accession synergies remain $30 million to $40 million for 2026.
- Q2 2026 revenue surged 30.4% to $1.68 billion, driven by contingents.
- July 22, 2026 AI partnerships target faster sales cycles and stronger margins.
What critics are saying
- Morgan Stanley cut Brown & Brown to Underweight on July 6, 2026.
- Organic revenue fell 0.7% in Q2 2026, exposing acquisition dependence.
- Florida property sensitivity and middle-market competition pressure margins, growth, and talent retention.
What makes Brown & Brown Insurance unique
- Brown & Brown combines national brokerage scale with 44 states and 14 countries.
- Its acquisition machine delivered Accession and $410 million Q2 2026 revenue.
- Management embeds Anthropic, McKinsey, and Accenture across workflows for AI productivity gains.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
401(k) Retirement Plan
401(k) Company Match
Student Loan Assistance
Tuition Reimbursement
Mental Health Support
Unlimited Paid Time Off
Paid Vacation
Paid Holidays
Company News
Brown & Brown shares are trading at a discount to the insurance brokerage industry, with a forward price-to-earnings ratio of 15.04X versus the industry average of 16.51X. The company has a market capitalisation of $23.96 billion. The stock has gained 27.4% over the past three months, outperforming the industry's 22.4% growth. Analysts' average price target of $76.44 suggests a potential 7.6% upside from recent levels. The Zacks Consensus Estimate projects 2026 earnings per share to increase 5.6% year-over-year, with revenues reaching $7.04 billion, up 19.2%. Growth is supported by increasing new business, strong client retention, and strategic acquisitions. The company's recent Accession acquisition contributed approximately $410 million to second-quarter 2026 revenues, with expected synergies of $30-$40 million in 2026.
Five insurance brokers stocks reported largely satisfactory Q2 earnings, with revenues beating analyst consensus estimates by 0.8% overall. Share prices have held steady, rising 2.1% on average since results were released. Brown & Brown reported revenues of $1.68 billion, up 30.4% year on year. However, this figure fell short of analyst expectations by 2.5%. Despite scoring the fastest revenue growth amongst peers, it had the weakest performance against analyst estimates. The stock has risen 2.7% since reporting and currently trades at $71.60. Ryan Specialty delivered the strongest Q2 performance, reporting revenues of $916.6 million, up 7.2% year on year and outperforming analyst expectations by 5.3%. The insurance brokerage industry benefits from rising risk complexity and regulatory scrutiny, though faces challenges from labour intensity and wage inflation.
Brown & Brown reported second quarter 2026 results that missed revenue expectations but showed strong year-on-year growth. Revenue rose 30.4% to $1.68 billion, below the $1.72 billion analyst estimate. Management attributed performance to strong contingent commissions, effective acquisition integration, and improved sales processes. CEO J. Powell Brown said the company's enhanced sales model is building momentum with aligned teams generating new business wins. Operating margin declined year-over-year to 22.9% from 24.2%, though the company made progress controlling expenses. Adjusted EBITDA of $611 million beat analyst estimates of $603.1 million. During the earnings call, analysts questioned MGA competition impacts, European expansion plans, and technology investment costs. Management stressed disciplined underwriting and confirmed synergy targets remain unchanged.
Brown & Brown reported Q2 2026 results with revenue of $1.676 billion and net income of $288 million. The insurance broker's shares closed at $70.40, posting a 22.16% gain over 90 days but down 9.30% year-to-date and 23.00% over one year. Valuation models suggest a fair value of $75.63, indicating the stock is 6.9% undervalued. The company's diversified portfolio across geographies and business lines supports earnings stability. However, the price-to-earnings ratio of 19.8x exceeds both the US insurance industry average of 12.1x and the stock's fair ratio of 12.5x. Risks include rising pharmacy costs in benefits and potential Florida legislative changes that could pressure margins.
Brown & Brown shares jumped 5% after reporting second-quarter results. The insurance brokerage firm's revenue grew 30.4% year-over-year to $1.68 billion, slightly below analyst estimates of $1.72 billion. Adjusted earnings per share came in at $1.07, exactly meeting Wall Street expectations. The positive market reaction suggests investors focused on strong top-line growth and profit targets rather than the minor revenue miss. The shares are down 5.9% year-to-date and trading at $73.05, which is 28.8% below their 52-week high of $102.58 from July 2025. Last month, Morgan Stanley downgraded the stock to "Underweight", citing concerns about organic growth reset and a softer pricing cycle.